London
· Delayed Price · Currency is GBP · Price in EUR Dr. Hönle AG Statistics
Total Valuation
Dr. Hönle AG has a market cap or net worth of GBP 39.17 million. The enterprise value is 80.31 million.
| Market Cap | 39.17M |
| Enterprise Value | 80.31M |
Important Dates
The next estimated earnings date is Wednesday, January 29, 2025.
| Earnings Date | Jan 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 38.44.
| EV / Earnings | -17.62 |
| EV / Sales | 0.96 |
| EV / EBITDA | 5.22 |
| EV / EBIT | 7.48 |
| EV / FCF | 38.44 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.59.
| Current Ratio | 1.98 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 3.05 |
| Debt / FCF | 22.43 |
| Interest Coverage | 5.87 |
Financial Efficiency
Return on equity (ROE) is -5.51% and return on invested capital (ROIC) is 5.18%.
| Return on Equity (ROE) | -5.51% |
| Return on Assets (ROA) | 4.56% |
| Return on Capital (ROIC) | 5.18% |
| Revenue Per Employee | 146,022 |
| Profits Per Employee | -7,953 |
| Employee Count | 594 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 0.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.32% in the last 52 weeks. The beta is 1.68, so Dr. Hönle AG's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | -57.32% |
| 50-Day Moving Average | 8.97 |
| 200-Day Moving Average | 15.61 |
| Relative Strength Index (RSI) | 39.69 |
| Average Volume (20 Days) | 6,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Hönle AG had revenue of GBP 83.67 million and -4.56 million in losses. Loss per share was -0.77.
| Revenue | 83.67M |
| Gross Profit | 59.64M |
| Operating Income | 10.72M |
| Pretax Income | -3.97M |
| Net Income | -4.56M |
| EBITDA | 14.07M |
| EBIT | 10.72M |
| Loss Per Share | -0.77 |
Balance Sheet
The company has 5.68 million in cash and 46.86 million in debt, giving a net cash position of -41.18 million.
| Cash & Cash Equivalents | 5.68M |
| Total Debt | 46.86M |
| Net Cash | -41.18M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 79.34M |
| Book Value Per Share | 13.08 |
| Working Capital | 25.83M |
Cash Flow
In the last 12 months, operating cash flow was 4.09 million and capital expenditures -2.00 million, giving a free cash flow of 2.09 million.
| Operating Cash Flow | 4.09M |
| Capital Expenditures | -2.00M |
| Free Cash Flow | 2.09M |
| FCF Per Share | n/a |
Margins
Gross margin is 71.28%, with operating and profit margins of 12.81% and -5.45%.
| Gross Margin | 71.28% |
| Operating Margin | 12.81% |
| Pretax Margin | -4.74% |
| Profit Margin | -5.45% |
| EBITDA Margin | 16.81% |
| EBIT Margin | 12.81% |
| FCF Margin | 2.50% |
Dividends & Yields
Dr. Hönle AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -11.64% |
| FCF Yield | 5.33% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Hönle AG has an Altman Z-Score of 2.34. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | n/a |